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Abstract
Background: In the auditory brainstem, ventral cochlear nucleus (VCN) axons project to the contralateral, but not
ipsilateral, medial nucleus of trapezoid body (MNTB), terminating in the calyx of Held. Dorsal VCN neurons, representing
high frequencies, synapse with medial MNTB neurons, while low frequency-coding ventral VCN neurons synapse with
lateral MNTB neurons, reflecting tonotopic organization. The mechanisms that ensure strictly contralateral targeting
and topographic ordering are incompletely understood. Here we examined the roles of ephrin-A signaling in both
types of targeting.
Results: Ephrin-A2 and ephrin-A5 are expressed in VCN cells during late embryonic and early postnatal development.
At these ages ephrin-A2 is expressed in axons surrounding MNTB and ephrin-A5 is expressed in MNTB principal
neurons. Ephrin-A2/A5 double knockout mice displayed axon targeting errors in which VCN axons project to MNTB on
both sides of the brainstem, where they terminate in calyceal endings. Ephrin-A2 and ephrin-A5 single knockout mice
showed a similar phenotype. In contrast to effects on contralateral targeting, ephrin-A2/A5 double knockout mice
showed no defects in formation of tonotopically ordered projections from VCN to MNTB.
Conclusions: These findings demonstrate that distinct mechanisms regulate targeting of VCN axons to the
contralateral MNTB and targeting to appropriate tonotopic locations. Ephrin-A signaling plays a similar role to ephrin-B
signaling in the VCN-MNTB pathway, where both classes normally prevent formation of calyceal projections to
ipsilateral MNTB. These classes may rely in part on common signaling pathways.
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Background
Specialized neural circuits in the auditory brainstem
underlie the computation of interaural time and inten-
sity differences used in sound localization. In mammals,
ventral cochlear nucleus (VCN) neurons receive input
from central projections of spiral ganglion cells. VCN
globular bushy cell axons cross the midline and termin-
ate in the contralateral medial nucleus of the trapezoid
body (MNTB) with large specialized endings known as
calyces of Held [1]. MNTB neurons send inhibitory
projections to ipsilateral LSO, where the balance of ex-
citation and inhibition is used to determine interaural
intensity differences. Central auditory pathways display
tonotopic maps reflecting the ordered frequency select-
ivity of the sensory epithelium [2]. In VCN the dorso-
ventral axis represents high-to-low best frequencies.
Neurons along this axis project topographically to the
mediolateral axis of the contralateral MNTB. The
VCN-MNTB projection to the appropriate side and
tonotopic location reflects specificity that arises initially
during axon outgrowth.
During development VCN axons initially reach the
midline by embryonic day 13 (E13) and extend to the
contralateral MNTB by E17 [3, 4]. The synaptic ter-
mination forms at postnatal day 0 (P0) and displays a
calyceal morphology at P4-P5 [5–8]. The protracted
and orderly growth of these axons reflects the coor-
dinated activity of several families of axon guidance
molecules.
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Guidance cues include the Eph family proteins, which
comprise the Eph receptor tyrosine kinases and their
ephrin ligands. These cell surface proteins facilitate cell-
cell interactions that play significant roles in axon guid-
ance, cell migration, and other processes [2, 9–11]. This
large family of proteins is subdivided into A and B clas-
ses based on sequence homology and binding affinity
[12]. Ephrin-A ligands bind to EphA receptors and
ephrin-B ligands bind to EphB receptors. Crosstalk be-
tween the classes emerges from exceptions to this speci-
ficity in that ephrin-B ligands bind to EphA4 and
ephrin-A5 binds to EphB2 [12–14].
Studies in mutant mouse models have revealed roles
for Eph proteins in establishing VCN-MNTB projec-
tions and tonotopy. VCN axon projections to MNTB
are almost entirely contralateral in the auditory brain-
stem of wild type mice, but in ephrin-B2lacZ/+ and
EphB2−/−;EphB3−/− mice, which have diminished EphB
signaling, a significant number of ipsilateral calyceal
projections to MNTB were found [8, 15]. Ipsilateral
projections in these mice form at the same time as the
normal contralateral projection and do not appear to
be eliminated in later maturation. In spite of these sig-
nificant numbers of aberrant ipsilateral projections, the
majority of inputs to MNTB arise as branches from
contralaterally projecting VCN axons. Evidence estab-
lishing a role for EphB proteins in central tonotopic
map formation comes from a study in which mutant
mice were exposed to pure tones and patterns of neur-
onal activation in the auditory brainstem nuclei were
examined. Results suggest that ephrin-B2 is needed to
form appropriately restricted tonotopic maps in the
dorsal cochlear nucleus [16].
Auditory brainstem phenotypes associated with EphB
mutations thus show significant effects but suggest that
other molecules contribute to specificity in circuit for-
mation. The goal of this study was to evaluate the con-
tributions of EphA signaling. Ephrin-A2 and ephrin-A5
display graded expression levels in retinal axons, and
mutations in Ephrin-A2 and ephrin-A5 have been
shown to disrupt topographic ordering of projections in
the developing visual system [17–20]. In the peripheral
auditory system ephrin-A2 and ephrin-A5 are
expressed in the cochlea where they regulate afferent
axon targeting [21, 22]. Null mutations in ephrin-A2
and ephrin-A5 result in frequency-specific abnormal-
ities in auditory brainstem responses that show central
as well as peripheral effects [23]. Within the auditory
brainstem, ephrin-A5 is expressed in the developing
cochlear nucleus and MNTB neurons during embry-
onic and postnatal ages [8]. Here we examined the
function of ephrin-A2 and ephrin-A5 in contralateral





We examined expression of ephrin-A2 in the auditory
brainstem during the development of the VCN-MNTB
pathway. At E17 ephrin-A2 immunolabeling showed
patchy expression in MNTB at low levels, particularly in
comparison to the regions surrounding MNTB (Fig. 1a).
In VCN ephrin-A2 expression was seen diffusely through-
out in a fibrous pattern that did not appear to correlate
with cell bodies (Fig. 1b). Similar expression patterns were
seen at P0 (Fig. 1c, d). At P4 this pattern continued, with
greater expression in the region dorsal to MNTB (Fig. 1e)
and similar expression in VCN (Fig. 1f). At P12 very little
expression was seen in MNTB (Fig. 1g) and expression in
VCN had diminished in comparison to younger ages
(Fig. 1h).
Ephrin-A5 expression
Similar to results reported in CD-1/129 mice [8],
ephrin-A5 expression was observed in C57BL/6 J mice
within MNTB and VCN at E17, P0, and P4 (Fig. 2a-f ).
At E17 (Fig. 2a-b) and P0 (Fig. 2c-d) expression was
sparse and diffuse. At P4, expression appeared most con-
centrated around cell bodies of MNTB (Fig. 2e). The
morphology of labeled regions (Fig. 2e, inset) corre-
sponds with either calyceal terminations on MNTB cells
or with MNTB cell surfaces. Expression of ephrin-A5 in
both nuclei at P12 was lighter compared to earlier ages.
Ephrin-A2 and ephrin-A5 regulate axon targeting to
contralateral MNTB
To evaluate the role of ephrin-A2 and ephrin-A5 in the
formation of contralateral axon projections from VCN
to MNTB, we performed neuroanatomical tracing in
wild type mice and in mice with mutations in ephrin-A2
and ephrin-A5. Lipophilic fluorescent dye was placed in
the VCN on one side. After the dye was transported into
the VCN axon projections, coronal sections were cut
and calyceal terminations could be readily identified in
MNTB. Brainstems with adequate label and at least 50
calyces were included in the analysis. The presence of
calyces in MNTB both ipsilateral (MNTBi) and contra-
lateral (MNTBc) to the dye placement was evaluated
(Fig. 3a). In wild type mice, the majority of axonal termi-
nations from VCN were found in MNTBc and few or no
calyces were present in MNTBi (Fig. 3b,c). In brainstem
sections of ephrin-A2/ephrin-A5 double knockout
(DKO) mice, we observed normal contralateral calyces
(Fig. 3d), but in addition we found numerous aberrant
ipsilateral projections (Fig. 3e), indicating significant
errors in axon targeting. Projections from VCN to
MNTBi terminated in a calyceal structure similar to that
seen in the normal, contralateral projection. To evaluate
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Fig. 1 Ephrin-A2 expression in the developing auditory brainstem shown in coronal sections. a At E17 ephrin-A2 is expressed in regions surrounding
MNTB, with relatively lighter, patchy label within MNTB. b At E17 light, fibrous expression of ephrin-A2 is seen throughout VCN. c At P0 expression is
seen just outside MNTB with sparse expression inside the nucleus. d Expression remains in VCN. e At P4 expression outside MNTB has increased. Inset
shows light label within MNTB. f Expression remains in VCN; inset shows fibrous label. g Expression of ephrin-A2 is greatly diminished in MNTB at P12.
h At P12 ephrin-A2 expression is relatively decreased in VCN compared to earlier ages. Scale bar in G, 200 μm, applies to A, C, E, G. Scale bar in H,
200 μm, applies to B, D, F, H. Scale bar in insets, 20 μm
Fig. 2 Ephrin-A5 expression in the developing auditory brainstem. a At E17 MNTB shows diffuse expression of ephrin-A5. b Low expression levels are
seen in VCN at E17. c At P0 ephrin-A5 is expressed in MNTB. d VCN expression has slightly increased at P0. e At P4 ephrin-A5 surrounds cell bodies in
MNTB (inset) and expression levels have increased. f Expression is seen throughout VCN with a diffuse pattern (inset). g By P12 immunolabeling shows
little expression in MNTB. h VCN shows low expression levels at P12. Scale bar in G, 200 μm, applies to A, C, E, G. Scale bar in H, 200 μm, applies to B,
D, F, H. Scale bar in insets, 20 μm
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Fig. 3 (See legend on next page.)
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the function of each protein individually, mice with sin-
gle null mutations in ephrin-A2 and ephrin-A5 were ana-
lyzed. Similar to the ephrin-A2/ephrin-A5 DKO mice,
ephrin-A2 (Fig. 3f, g) and ephrin-A5 (Fig. 3h, i) knockout
(KO) mice both displayed mistargeting of VCN axons
with calyces forming in MNTBi as well as in MNTBc.
To quantify the effects of mutations on axon targeting,
we counted all the labeled calyces throughout MNTB on
both sides of the brain and obtained a ratio of ipsilateral
to contralateral calyces (I/C ratio) for each animal (Fig. 3j).
For wild type mice (n = 16, mean total calyces labeled =
167 ± 56; s.e.m.) the mean I/C ratio was 0.069 ± 0.012,
indicating that, as expected, the majority of inputs were
seen on the contralateral side. For ephrin-A2/A5 DKO
mice (n = 6; mean total calyces labeled = 162 ± 81) the
mean I/C ratio was 0.19 ± 0.021. For ephrin-A2 KO
mice (n = 21, mean total calyces labeled = 193 ± 97)
the I/C ratio was 0.158 ± 0.019, and for ephrin-A5 KO
mice (n = 13, mean total calyces labeled = 191 ± 148)
the I/C ratio was 0.175 ± 0.018 (Fig. 2j). The total
number of calyces measured in each brainstem did
not differ among groups (one-way ANOVA; p = 0.82).
Values for I/C ratios were normally distributed. A
one-way ANOVA with Tukey-Kramer post-hoc ana-
lysis was used to compare the I/C ratios. We found
significant differences between the mean I/C ratio of
wild type mice compared to ephrin-A2/A5 DKO mice
(p < 0.004); ephrin-A2 KO mice (p < 0.002); and
(See figure on previous page.)
Fig. 3 Ephrin-A2 and ephrin-A5 regulate contralateral targeting of VCN axons. a Schematic diagram illustrating circuitry in the VCN pathway. Dye
placement in VCN on one side normally results in labeled calyces in contralateral MNTB (MNTBc) but not in ipsilateral MNTB (MNTBi). b In wild
type mice numerous calyces are labeled in MNTBc. c Labeled terminations were not formed in MNTBi in wild type mice. d In ephrin-A2/A5 double
knockout mice, VCN axons terminated in MNTBc. e In addition to the normal projection, ephrin-A2/A5 double knockout mice also displayed numerous
terminations in MNTBi, indicating significant errors in axon targeting. These projections ended in large terminations with morphology similar to the
calyx of Held found in contralateral projections. f, g Ephrin-A2 single knockout mice showed a similar phenotype to ephrin-A2/A5 double knockout
mice, with normal contralateral calyces as well as terminations in MNTBi. h, i Similarly, Ephrin-A5 single knockout mice showed both contralateral and
ipsilateral calyceal terminations. j To compare axon targeting errors between groups we used the ratio of calyces in MNTBi to MNTBc, the I/C ratio.
Using ANOVA with post hoc analysis, we found a significant increase in I/C ratio for all three mutant mouse groups compared to wild type mice. I/C
ratios for mutant mice did not differ significantly from each other. Scale bar in I indicates 100 μm for B-I
Fig. 4 Topographic mapping in wild type and ephrin-A2/A5 double knockout mice. a Schematic diagram showing the expected outcome of
ventral dye placements in wild type mice, with labeled calyces seen in the lateral portion of the contralateral MNTB. b Labeled calyces in MNTBc
after a ventral dye placement in VCN in a wild type animal. The normalized location of a calyx along the mediolateral axis is denoted with an
asterisk; normalized positions were averaged to obtain values for each animal. As expected, the calyces are clustered in the lateral portion of
MNTBc. c No calyces are seen in the MNTBi. d Section through the VCN of this animal shows the dye placement in the ventral region, with the
center indicated (asterisk). e Schematic diagram depicting dye labeling in an ephrin-A2/A5 double knockout mouse. Dorsal dye placement into
the high frequency region of VCN results in labeled terminations in the medial regions of both MNTBc and MNTBi. f Labeled calyces in MNTBc
after a dorsal dye placement in VCN in an ephrin-A2/A5 double knockout mouse. Calyces appear clustered in the medial region. g Ipsilateral
calyces are found in medial MNTB regions after dorsal dye placement in ephrin-A2/A5 double knockout mice. h Section through the VCN of this
animal shows the dye placement in the dorsal region, with the center indicated (asterisk). Scale bar in G indicates 100 μm for B, C, F, and G. Scale
bar in H indicates 100 μm for D and H
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ephrin-A5 KO mice (p < 0.001). The I/C ratios did not
differ significantly between any of the mutant mouse
groups.
Ephrin-A2 and ephrin-A5 mutations do not affect VCN-
MNTB topography
We next tested the role of ephrin-A ligands in the forma-
tion of the topographic projection from the dorsoventral
VCN axis to the mediolateral MNTB axis, which repre-
sent the frequency axes of these nuclei (Fig. 4a). As ex-
pected, small deposits of lipophilic dye in the dorsal or
ventral VCN of wild type mice (n = 16) resulted in labeled
calyces in the medial or lateral portion of the contralateral
MNTB, respectively. A representative example of a ventral
dye placement is shown in Fig. 4b-d.
Focal dye labeling experiments were similarly performed
in ephrin-A2/A5 DKO mice (n = 7) and the positions of
labeled calyceal terminations in MNTB were evaluated as
above. A representative example illustrating dye place-
ment in the dorsal portion of VCN is shown in Fig. 4e-h.
Calyceal labeling is seen in the medial portion of both the
MNTBc (Fig. 4f) and MNTBi (Fig. 4g).
We used the normalized mean center of the dye place-
ment in VCN across sections to assess the dorsoventral
position of the labeled area for each animal. The mean
normalized mediolateral position of calyces in MNTB
was used as a measure of location of terminations for
each animal. We found a strong positive linear correl-
ation between VCN dye position and contralateral
MNTB calyx position in wild type animals (regression
line y =1. 33x - 0.11; R2 = 0.78; Fig. 5a). A scatter plot of
the mean dorsoventral VCN dye placement position and
resulting mean mediolateral positions of calyces in
MNTB showed a strong positive linear correlation for
both the ipsilateral (y = 1.63x - 0.22; R2 = 0.75) and
contralateral (y = 1.43x - 0.37; R2 = 0.72) MNTB (Fig. 5b).
The slope and correlation coefficients for both MNTBc
and MNTBi were similar to results seen in wild type mice,
indicating that both ipsilateral and contralateral projec-
tions displayed topographic mapping in ephrin-A2/A5
DKO mice.
We observed a slight lateral shift in the position of ipsi-
lateral calyces compared to contralateral calyces labeled
by the same VCN injections. In a two-tailed paired t-test
for the comparing mean position of ipsilateral vs. contra-
lateral calyces in ephrin-A2/A5 DKO mice (n = 7), we
obtained a p-value of 0.018, indicating that this lateral shift
is statistically significant. Together, these observations
suggest that ephrin-A2/A5 DKO mice show normal topo-
graphic mapping to contralateral MNTB, and further sug-
gest that aberrant ipsilateral VCN-MNTB projections in
these mice follow topographic mapping cues with some
differences compared to the contralateral projection.
Discussion
The projection from VCN to MNTB is almost entirely
contralateral, and this precision is disrupted when EphB
signaling is inhibited. However, a significant proportion
of the projection remains contralateral in mice with loss
of EphB signaling [15], indicating that additional mecha-
nisms ensure that VCN axons terminate contralaterally.
Here we explored the potential function of EphA signal-
ing. We determined the expression patterns of ephrin-A2
and ephrin-A5 and characterized axon targeting in VCN-
MNTB projections of mice lacking one or both proteins.
We explored both contralateral targeting and topographic
mapping to determine the functions of these proteins.
We found that ephrin-A2 and ephrin-A5 are expressed
in the brainstem during embryonic and early postnatal
development. Ephrin-A2 is expressed in VCN, where the
Fig. 5 Topographic mapping is similar in wild type and ephrin-A2/A5 double knockout mice. a Scatter plot assessing topography using wild type
mice (n = 16) shows a strong positive correlation between dye position in VCN and mean normalized position of contralateral calyces, with dorsal
VCN regions projecting to medial MNTB, and ventral VCN projecting to lateral MNTB. b Analysis of topographic mapping in ephrin-A2/A5 double
knockout mice (n = 7). The regression line and correlation coefficient is similar to results seen in wild type mice for projections to MNTBc as well
as MNTBi. In these mice the ipsilateral calyces were significantly shifted laterally relative to the contralateral calyces
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diffuse label is consistent with neuronal and/or glial la-
beling. It does not appear to be expressed within MNTB
but rather in the fibers surrounding the nucleus. This
protein may thus act early on VCN axons and may influ-
ence their growth en route to their targets in MNTB.
Ephrin-A5 is expressed in both VCN and MNTB at P4.
In MNTB the labeled region is seen around MNTB cells,
a pattern consistent with labeling on the MNTB cell sur-
face or in the calyx of Held. Ephrin-A5 immunolabeling
is unlikely to represent glial cells given the fibrous
morphology of glial markers in MNTB at early ages [24].
Null mutations in ephrin-A2 and/or ephrin-A5 both result
in the formation of substantial ipsilateral VCN-MNTB pro-
jections in addition to the normal contralateral projection.
Despite these similar phenotypes between ephrin-A2 KO
and ephrin-A5 KO mice, the differing expression patterns
suggest that ephrin-A2 and ephrin-A5 proteins act at differ-
ent points in VCN axon growth. In contrast to these effects
on contralateral axon targeting, the ephrin-A2/A5 DKO
mice showed normal topographic mapping from VCN to
MNTB on both sides.
Role of ephrin-A2 and ephrin-A5 in targeting to
contralateral MNTB
Analysis of VCN projections in mutant mice revealed
improper targeting to ipsilateral MNTB when ephrin-A2
and/or ephrin-A5 are deleted. This observation is similar
to that previously reported for mice with reduced sig-
naling through the ephrin-B signaling pathways. Quan-
titatively, the I/C ratio values are similar to those of
ephrin-B2lacZ heterozygous mutations and EphB2/B3
double mutants [15]. This similarity may arise from the
two classes of ligands acting on common targets.
Ligands are promiscuous within their own class but
there is also a degree of crosstalk between classes, and
the EphB2 receptor can bind with ephrin-A5 ligand
[12–14]. Similar phenotypes in mice lacking ephrin-A5
and EphB2/B3 suggest that regulation of contralateral
targeting relies in part on ephrin-A5-EphB2 binding.
While binding between ephrin-A2 and EphB receptors
has not been demonstrated, the similarity in phenotypes
in contralateral targeting of the VCN-MNTB pathway
suggests that signaling through Eph proteins may con-
verge on a common molecular pathway, possibly through
other more complex molecular interactions [2, 25–28].
Additionally, distinct Eph proteins may act at different
times, resulting in convergent effects of mutations. Eph
proteins influence axon growth and branching at early
stages and synaptogenesis at later stages. In the developing
MNTB, numerous synapses are formed initially and
excess synapses are eliminated during the first postnatal
week [29]. It is unclear whether any of the early-
eliminated synapses are ipsilateral, but by the time the
protocalyx is visible the projection is already nearly
entirely contralateral [15]. An interesting possibility is that
Eph signaling influences the process of branching in the
early MNTB and/or in subsequent synapse elimination.
Further evidence for multiple points of regulation lie in
the observation that in mutations affecting ephrin-B
signaling, ipsilateral projections to MNTB arose either as
branches from the contralateral projection of as direct
projections from VCN [15]. These effects suggest that
some aberrant projections arise from additional proximal
branching, whereas others reflect errors in initial axon
outgrowth. While the origin of ipsilateral projections is
not known for ephrin-A2 and ephrin-A5 mutations, the
similar phenotype suggests that both trajectories are likely.
Role of ephrin-A2 and ephrin-A5 in topographic targeting
Topographic mapping is seen throughout the central
nervous system and represents a fundamental organizing
principle of sensory pathways. Topography in a number
of pathways has been shown to arise from graded
expression of Eph proteins together with varying degrees
of activity-dependent refinement [30–32]. In visual
system pathways, formation of retinotopy relies exten-
sively on gradients of ephrin-A proteins [33, 34]. In con-
trast, we found that null mutations in ephrin-A2 and
ephrin-A5 had no effect on topographic mapping in the
VCN-MNTB pathway. Previous studies have suggested
that EphB proteins are needed for formation of tonotopy
in MNTB [16], the inferior colliculus [32, 35], and the
auditory cortex [36]. Our results suggest that ephrin-A2
and ephrin-A5 are not predominant factors in establish-
ment of the VCN-MNTB map in the brainstem. The
role of these proteins has not been established in projec-
tions from MNTB to its targets, including LSO. The
involvement of ephrin-A proteins is not ruled out in
other tonotopic projections, as EphA7 modulates tono-
topy in the corticothalamic projection from auditory
cortex [37]. Moreover, ephrin-A2/A5 DKO mice show
impaired topography in an experimentally induced ret-
inal projection into the medial geniculate nucleus of the
thalamus, which normally receives auditory input [38].
These observations suggest a role for EphA signaling in
the formation of topography in the auditory thalamus.
The roles of other ephrin-A proteins in establishing
tonotopy have yet to be identified.
Given that ephrin-A2/A5 DKO mice have a significant
ipsilateral projection, we analyzed this pathway to deter-
mine whether the aberrant projection displays topog-
raphy. We found that topography was similarly strong
on the ipsilateral and contralateral sides, indicating that
ordering of either projection does not rely critically on
ephrin-A2 and ephrin-A5 and instead both rely on other
cues. However, a significant lateral shift was noted in the
ipsilateral versus contralateral projection in ephrin-A2/
A5 DKO mice. This difference could arise from
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differences in expression of receptors for graded cues in the
target, which could emerge in crossed versus uncrossed
portions of VCN axons. Alternatively, the difference could
arise in the timing of growth of VCN axon branches to the
two sides. Identification of cues that establish tonotopy in
this pathway is needed to characterize differences between
the normal contralateral projection and the projection on
the ipsilateral side.
Conclusions
Our data show a role for ephrin-A2 and ephrin-A5 in
contralateral vs. ipsilateral targeting but not in topo-
graphic map formation, indicating that these cues arise
from distinct molecules. Conversely, ephrin-B signaling
is needed for topographic mapping of projections to the
IC, but not for targeting to discrete modular zones
within the IC [32]. In retinocollicular pathways, ephrin-
A proteins are necessary for topographic map formation,
but not for targeting to specific laminae within the su-
perior colliculus [19]. These observations show that Eph
signaling can selectively contribute to several distinct di-
mensions of targeting. The diversity of Eph proteins may
thus permit coordinated guidance to correct regions




All procedures were approved by the University of
California, Irvine Institutional Animal Care and Use
Committee (IACUC). We used wild type, ephrin-A2 KO
mice, ephrin-A5 KO mice and ephrin-A2/A5 DKO mice,
all on strain C57BL/6 J. Double knockouts were obtained
by breeding Efna2tm1JgfEfna5tm1Ddmo/J transgenic mice
(Jackson Laboratories), which contained homozygous de-
letion of ephrin-A2 and were heterozygous for ephrin-A5.
To determine animal genotypes, mice were anesthe-
tized with isoflurane. DNA was then extracted from tail
samples as described previously by [15]. Three primers
were used for the ephrin-A2 allele: oIMR8356, 5′-CCG
CTT CCT CGT GCT TTA CGG TAT C-3′; oIMR8357,
5′-GGC TAT ACC GTG GAG GTG-3′; and oIMR8358,
5′-CTG CCG GTG GTC ACA GGA-3′. The wild type
PCR product is 110 bp while the mutant product is
650 bp as reported by Jackson Laboratory.
The three primers used for the ephrin-A5 allele:
oIMR8359, 5′- ATT CCA GAG GGG TGA CTA CCA
CAT T-3′; oIMR8360, 5′- TCC AGC TGT GCA GTT
CTC CAA AAC A-3′; and oIMR8361, 5′- AGC CCA
GAA AGC GAA GGA GCA AAG C-3′. The wild type
PCR product is 397 bp while the mutant product is
513 bp as reported by Jackson Laboratory.
Immunofluorescence
Wild type mice at ages E17, P0, P4, and P12 mice were
used for immunofluorescence. Embryonic tissue was
immersion fixed in 4 % paraformaldehyde (PFA) in
phosphate-buffered saline (PBS) at 4 °C. P0 and P4 mice
were perfused transcardially with 0.9 % saline followed
by 4 % PFA in PBS. P0 and P4 brainstems were then dis-
sected and post-fixed for 2 h in 4 % PFA in PBS at 4 °C.
Samples were cryoprotected in 30 % sucrose in PBS at
4 °C. Brainstems were sectioned in the coronal plane at
18 μm on a cryostat (Leica Microsystems) and mounted
onto chrome-alum-subbed slides. Slides were outlined in
PAP pen (Life Technologies) to confine reagents and
warmed at 37 °C on a slide warmer for 20 min as de-
scribed previously [24]. Slides were rinsed in PBS for
30 min and then incubated 1 h in blocking solution
consisting of 4 % bovine serum albumin and 0.1 % Tri-
ton X-100 in PBS. The primary antibody for ephrin-A2
(5–15 μg/mL in blocking solution) was a goat polyclonal
antiserum generated using a recombinant mouse ephrin-
A2 protein (aa 1–184, R&D Systems). The primary anti-
body for ephrin-A5 (5 μg/mL) was a rabbit polyclonal
antiserum derived from the C-terminal end of the mouse
ephrin-A5 protein (aa 160–250, Invitrogen). Slides were
incubated overnight at room temperature with primary
antibody, rinsed in PBS for 30 min and then incubated in
secondary antibody for 1 h at room temperature. Second-
ary antibodies used were Alexa Fluor 488 donkey anti-
goat for ephrin-A2 and Alexa Fluor 594 goat anti-rabbit
for ephrin-A5 (1:300, Life Technologies). Slides were
rinsed in PBS for 30 min and coverslipped with Glycergel
mounting media (Dako). We confirmed the specificity of
the primary antibodies by including control sections de-
rived from ephrin-A2 KO mice or ephrin-A5 KO mice for
the ephrin-A2 and ephrin-A5 antibodies, respectively; no
labeling was seen in these sections.
Neuroanatomical labeling
Wild type, ephrin-A2 KO mice, ephrin-A5 KO mice, and
ephrin-A2/A5 DKO mice were used at P10-P14 for ana-
lysis of contralateral targeting. Wild type and ephrin-A2/
A5 DKO mice were used at P10-12 for analysis of topo-
graphic mapping. Mice were perfused transcardially with
0.9 % saline then 4 % PFA in PBS. Brainstems and cere-
bellum were extracted and post-fixed in 4 % PFA in PBS
at 4 °C for 24–72 h. The cerebellum was dissected away
and a small piece (100–200 μm2) of the lipophilic Neu-
roVue Red dye (Polysciences) was then placed in VCN
on one side as described previously [8, 39]. For studies
of topography, a smaller piece of NeuroVue Red dye was
placed on one side of either dorsal or ventral portion of
VCN. Brainstems were then returned to 4 % PFA in PBS
and incubated at 37 °C for 2 weeks to allow for dye to
transport along the axon and into the calyces on MNTB.
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Brainstems were placed in 4 % low-melting agarose in
PBS after incubation and sectioned coronally at 100 μm
on a vibratome (Leica Microsystems). Sectioned tissue
was then mounted onto chrome-alum-subbed slides and
coverslipped.
Imaging
Immunofluorescence images of brainstem sections were
acquired with a Carl Zeiss Axioskop microscope, Axiocam
digital camera and Axiovision software (Zeiss). Images
were then imported into Adobe Photoshop CS6 v13.0 for
brightness and contrast optimization. The boundaries of
VCN and MNTB were visualized in green autofluores-
cence images.
Analysis of contralateral targeting
The specificity of the VCN-MNTB pathway was ana-
lyzed by examining the number of calyceal terminations
from the labeled VCN to both contralateral MNTB and
ipsilateral MNTB, where the large calyceal terminations
can be clearly visualized and counted. Analysis was per-
formed blind to genotype. Samples were included in the
study if (1) labeled axons originated from an intact VCN
and coursed along the ventral region of the midline; (2)
axons terminated at calyces within MNTB; (3) calyceal
terminations covered at least one-fourth of the cell sur-
face in MNTB; and (4) at least 50 total labeled calyces
were found in the brainstem. To account for variations
in dye labeling across animals, we computed an ipsilat-
eral to contralateral ratio (I/C ratio) as described previ-
ously [8, 15, 39, 40] by dividing the total number of
MNTBi projections by the total number of MNTBc pro-
jections to obtain a single value for each animal. A one-
way ANOVA with post-hoc analysis was used to compare
the I/C ratios.
Analysis of topographic mapping
Brainstems were included in the analysis of topographic
mapping if (1) dye extended 50 % or less than the total
dorsoventral length of VCN; (2) dye was transported
along the axon from VCN and terminated in calyces;
and (3) dye labeled at least 10 calyces total in MNTBi
and MNTBc. Brainstems were excluded if dye was
located on parts of brainstem other than VCN or if no
calyces were labeled in MNTBc. Analysis was performed
blind to genotype.
Single 10x magnification green and red fluorescent im-
ages of VCN were taken to measure the ventral to dorsal
length of VCN and dye mean center using Axiovision
software (Zeiss). VCN was identified under green auto-
fluorescence and the most dorsal point of VCN was set
as 0 μm per section. The average length for each brain-
stem was calculated. The borders of dye placement along
the ventral to dorsal axis of VCN were determined using
the red fluorescence image and the midpoint of the dye
extent was used to determine the dye position relative to
the 0 μm reference:
VCN dye position ¼ ventral dye border ‐dorsal dye border2
 
þ dorsal dye border
The VCN dye position was normalized to the dorso-
ventral length of VCN. This normalized dye position
was averaged across all VCN sections containing dye la-
beling to obtain a single value for each animal.
The average dye extent was calculated to determine in-
clusion criteria for each brainstem:
Avg VCN dye extent ¼ mean ventral border‐mean dorsal border
average VCN length
X 100
Specimens with values 50 % and lower were included.
Z-stack 20x green and red fluorescent images were ob-
tained for MNTBi and MNTBc. The length of the ipsi-
lateral and the contralateral MNTB was measured in
each section from the most medial position to the most
lateral position using the green fluorescent image. The
positions of labeled ipsilateral and contralateral calyces
from the medial border MNTB were measured using the
z-stack red fluorescent images. For each calyx, the dis-
tance from the medial border was normalized to the
mediolateral width of MNTB in that section. The aver-
age normalized calyx position in MNTBi and MNTBc
was calculated for each brainstem.
A scatter plot of the VCN normalized dye position and
the MNTB normalized calyx position was constructed to
assess topographic mapping in wild type and ephrin-A2/
A5 double knockout mice. Linear regressions were used
to assess the correlation between the location of the
VCN dye placement and locations of calyces in MNTB.
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